US And Canada

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

OSI's chief executive Charles Conn stepped down from the fund last November after only eight months, leaving CFO Jim Wilkinson in the post on an interim basis.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

March Capital has led a round that boosted the overall funding for the Stanford-backed enterprise data management platform to $75m.

AI2's new pre-seed fund will help create 12 new spinouts in fields such as deep learning, computer vision and natural language processing.

Wilson Sonsini Goodrich & Rosati has invested in genomic sequencing amplification business Bioskryb, co-founded by Stanford faculty member Charles Gawad.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.